Metoprolol Succinate Tablet, Extended Release
Product Images NDC 71765-008

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 71765-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zhejiang Jutai Pharamceutical Co., Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Metaprolol 01)

Structure (Metaprolol 01)
Chemical structure diagram of Metoprolol succinate, showing the molecular arrangement including benzene ring and succinate moiety.*
FDA Label Image

Figure (Metaprolol 02)

Figure (Metaprolol 02)
A forest plot chart titled 'Results for Subgroups in MERIT-HF,' showing relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. The chart compares metoprolol succinate extended-release tablets versus placebo across various patient subgroups, with key clinical metrics like NYHA class, ejection fraction, ischemic etiology, sex, race, myocardial infarction history, diabetes status, hypertension status, and heart rate.*
FDA Label Image

50 mg 100 Count (Metaprolol 03)

50 mg 100 Count (Metaprolol 03)
Label for Metoprolol Succinate Extended-Release Tablets USP, 50 mg strength. The label indicates 100 tablets per container, Rx only. It lists the manufacturer as Zhejiang Jutai Pharmaceutical Co., Ltd and includes dosage and warning information alongside a barcode.*
FDA Label Image

50 mg 1000 Count (Metaprolol 04)

50 mg 1000 Count (Metaprolol 04)
Label for Metoprolol Succinate Extended-Release Tablets, USP 50 mg in a bulk package of 1000 tablets. The label identifies the product for oral use and prescription only, manufactured by Zhejiang Jutai Pharmaceutical Co., Ltd. It includes dosage details, warnings, barcode, and storage instructions.*
FDA Label Image

100 mg 100 Count (Metaprolol 05)

100 mg 100 Count (Metaprolol 05)
Metoprolol succinate extended-release tablets, USP 100 mg, oral dosage form, in a 100-tablet package by Zhejiang Jutai Pharmaceutical Co., Ltd. The label includes NDC 71765-007-01, barcode, handling warnings, and manufacturer details. It is marked Rx only and specifies storage conditions.*
FDA Label Image

100 mg 1000 Count (Metaprolol 06)

100 mg 1000 Count (Metaprolol 06)
Label for Metoprolol Succinate Extended-Release Tablets, USP 100 mg, oral tablets, bulk package of 1000 tablets by Zhejiang Jutai Pharmaceutical Co., Ltd. The label includes NDC 71765-007-02, dosage strength, manufacturer information, storage instructions, and a caution that this bulk package is not intended for dispensing individually.*
FDA Label Image

200 mg 100 Count (Metaprolol 07)

200 mg 100 Count (Metaprolol 07)
Label for Metoprolol Succinate Extended-Release Tablets, USP 200 mg, oral dosage form, supplied in a package of 100 tablets. The label includes NDC 71765-008-01 and is manufactured by Zhejiang Jutai Pharmaceutical Co., Ltd. It provides storage instructions and a caution that the product is Rx only. The label features a barcode and the Yosemade logo.*
FDA Label Image

200 mg 1000 Count (Metaprolol 08)

200 mg 1000 Count (Metaprolol 08)
Metoprolol Succinate Extended-Release Tablets USP 200 mg bulk package label showing 1000 tablets. The label includes the NDC 71765-008-02 and states that it is RX only. Manufactured by Zhejiang Jutai Pharmaceutical Co., Ltd. The label includes handling and storage instructions, a barcode, and a note that this bulk package is not intended for dispensing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.